Cancer Patients Use Music to Soothe Presurgical Anxiety
September 1st 1997NEW ORLEANS-Surgical oncol-ogy patients appear to be overwhelmingly in favor of listening to music before and after their surgery. Besides its soothing powers, music may help in pain control, offering a cost-effective intervention, investigators reported at the Oncology Nursing Society.
FDA Approves Taxol for Use in AIDS-Related KS
September 1st 1997ROCKVILLE, Md-The Food and Drug Administration (FDA) has cleared Bristol-Myers Squibb’s Taxol (paclitaxel) Injection for use in the second-line treatment of AIDS-related Kaposi’s sarcoma (KS). Taxol is also approved for second-line use in metastatic breast and ovarian cancer.
AACR Urges Tobacco Industry Support of Cancer Research
September 1st 1997PHILADELPHIA-The proposed tobacco settlement should include support for federally funded cancer research “in proportion to the devastation caused by tobacco-induced cancers on our public health,” the American Association for Cancer Research said in a position statement.
Panel Gives Platelet Growth Factor Nod of Approval
September 1st 1997MADISON, NJ-The Biological Response Modifiers Advisory Committee unanimously recommended that the Food and Drug Administration approve Neumega (recombinant human inter-leukin-11 or rhIL-11), Genetics Institute’s platelet growth factor. Genetics Institute is a subsidiary of American Home Products Corporation.
Panel Recommends FDA Approve First MoAb for Cancer Rx
September 1st 1997BETHESDA, Md-The Biological Response Modifiers Advisory Committee has recommended that the FDA usher cancer therapy into a new era by approving IDEC Pharamceutical’s Rituxan (rituximab) for patients with relapsed or refractory low-grade or follicular B-cell non-Hodgkin’s lymphoma.
Clinton Proposes New Law on Patient Privacy
September 1st 1997WASHINGTON-The Clinton Administration soon will propose a federal law aimed at protecting the privacy of medical records. The law would allow disclosure of medical records only for reasons of health care. For example, if an employer gained access to an employee’s records during the claims process, the company would not be allowed to use the information in any way that would affect the employee’s job, such as in considering promotions or assignments.
Society of Surgical Oncology Practice Guidelines: Introductory Remarks
September 1st 1997Thousands of practice guidelines/practice parameters have been published by various professional organizations. The American Medical Association,[1] American College of Physicians,[2,3] and others[4-6] have written extensively about
Prostate-Specific Antigen: What’s New in 1997
September 1st 1997This review of prostate-specific antigen (PSA) by Pannek and Partin, two experts in the prostate marker field, comes at a very good time-a point at which great changes are occurring after a relatively long period of stability. I expect that this trend will continue. Moreover, given the rapid developments occurring in this area, some of the statements made in both the review and my commentary will probably need to be modified within the next 12 months, with further revisions necessary thereafter.
Precise Clinical Staging Allows Treatment Modification of Patients With Esophageal Carcinoma
September 1st 1997Treatment of esophageal carcinoma requires the realization that this neoplasm is not a single entity with a uniformly poor prognosis. As with any other malignancy, disease stage has prognostic and therapeutic
Two-Step Approach Urged to Avoid High Tech, Wild Death
August 1st 1997HOUSTON--In the current health care environment, peaceful deaths are seriously threatened as clinicians attempt technological brinkmanship and patients and families demand that "everything be done" to extend life, said Rebecca Pentz, PhD, a clinical ethicist at The University of Texas M.D. Anderson Cancer Center.
Health Insurance Premiums Tax Proposed
August 1st 1997WASHINGTON--To maintain its world leadership in clinical care, the nation should levy a 1% tax on health care premiums to pay for clinical research, Kenneth I. Shine, MD, president of the National Academy of Sciences' Institute of Medicine (IOM), has proposed.
ODAC Votes Yes on Taxol for Kaposi's Sarcoma
August 1st 1997BETHESDA, Md--The FDA's Oncology Drugs Advisory Committee (ODAC) voted 8 to 4 to recommend that the agency grant traditional new drug approval to Bristol-Myers Squibb's Taxol for Injection Concentrate (paclitaxel) for the second-line treatment of AIDS-related Kaposi's sarcoma (KS).
Five Principles Help Resolve Ethical Dilemmas in Care
August 1st 1997SEATTLE--Physicians and nurses frequently confront ethical dilemmas in caring for cancer patients, and these must be resolved on an individual basis, through established principles, Tom McCormick, DMin, senior lecturer in medical ethics, University of Washington, told the Association of Pediatric Oncology Nurses. "I don't think we'll ever see the day," he said, "when we can put all of the alternatives into a computer, press a button, and ask the computer to come up with a decision."
With Genetic Tests, Informed Consent Enters Psychosocial Realm
August 1st 1997NEW ORLEANS--Informed consent has historically focused on physical risks, but genetic testing will move informed consent into psychosocial areas, Karen Rothenberg, JD, MPA, Marjorie Cook Professor of Law, University of Maryland School of Law, said at the 21st annual meeting of the American Society of Preventive Oncology (ASPO).
External Beam Radiation and Brachytherapy for Prostate Cancer: Worthwhile Long-Term Outcomes
August 1st 1997Long recognized as standard treatment of gynecologic cancer and some other malignancies, brachytherapy may also play a role in the treatment of prostate cancer, said Dr. John C. Blasko of the University of Washington in Seattle.
Urologists Urged to Get on Board With Prostate Brachytherapy
August 1st 1997PALM BEACH, Fla--A urologist believes his unique viewpoint can be helpful to radiation oncologists doing brachy-therapy and to his fellow urologists. "By 2005," said Nelson Stone, MD, of Mt. Sinai Medical Center, NY, "projections indicate that two thirds of prostate cancer cases will be treated with brachyther-apy or external beam irradiation. If urologists don't get on board, they'll be treating half of the cases they are now."
Research Helps Shed Light on Role of Apoptosis in Tumor Development and Growth
August 1st 1997Many types of cells undergo apoptosis as part of the normal physiological process. An interruption in apoptosis is thought to be a primary cause of tumor growth. Two presentations concerning this subject were made at the 88th Annual Meeting of the
American Cancer Society Now a More Aggressive Advocate
August 1st 1997WASHINGTON--This spring, the American Cancer Society (ACS) and the Children's Defense Fund led an influential coalition of more than 150 groups in active support of the CHILD Act, sponsored by Sen. Orrin G. Hatch (R-Utah) and Sen. Edward M. Kennedy (D-Mass).